FormDSignal
15

Andira Medicine Inc. files Form D

Company raise update · Raising · North Vancouver, British Columbia, Canada · Form D/A filed 2025-09-05

How this compares

  • No earlier fund launch by this sponsor appears on EDGAR.

Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.

Raise progress

FiledFormSoldInvestorsChange
2025-09-05D/A$810K5
2026-03-12D$152K3−$658K
2026-08-18D$100K1−$52K
2026-09-04D/A$810K5+$710K
2026-10-09D$120K1−$690K

Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.

Andira Medicine on EDGAR

Earlier and related filings by the same issuer and sponsor.

15

Andira Medicine Inc. files Form D

Company raise update · Raising · Offering $1.6M · Sold $810K · North Vancouver, British Columbia, Canada · filed 2026-09-04

Sold rose to $NaN (+$710K, +4 investors) in 17 days since the previous filing.

People on the filing

Janette Stuart LyonsExecutive Officer
Michael Stuart WallDirector
Dana LambertDirector, Executive Officer
Ethan RussoDirector
Ammad Stuart ShorbajiExecutive Officer

Signed by Dana Lambert, CEO.

Why now — by persona

Relevant to: B2B software & services sales.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans.